Related Experiment Video
Updated: Jun 27, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Cystic thymoma coexisting with vascular dysplasia
T Papadas1, P A Dimopoulos, F Sampsonas
1Department of Otolaryngology, University Hospital, Rion, Patras, Greece.
European Review for Medical and Pharmacological Sciences
|November 26, 2008
Summary
A rare case of cystic thymoma with extensive vascular dysplasia presented with chest pain and dyspnea in a young woman. This unique presentation required advanced imaging and surgical intervention, highlighting a novel clinical scenario.
Area of Science:
- Thoracic surgery
- Vascular surgery
- Oncology
Background:
- Thymoma is a rare tumor originating from the thymus gland.
- Vascular dysplasia involves abnormal development of blood vessels.
- Mediastinal masses can present with diverse and complex symptoms.
Observation:
- A 23-year-old female presented with right shoulder, chest, and ear pain, cough, and dyspnea.
- Imaging revealed a mediastinal mass contiguous with a large mass in the thorax, axilla, and neck.
- Surgical exploration identified a cystic thymoma in contact with extensive vascular dysplasia.
Findings:
- The cystic thymoma was surgically removed.
- The extensive vascular dysplasia was a unique co-occurrence.
- Post-operative follow-up confirmed the rarity of this combined condition.
Implications:
- This case expands the differential diagnosis for mediastinal masses.
- It underscores the importance of comprehensive imaging in complex thoracic presentations.
- Further research may elucidate the pathogenesis of concurrent thymoma and vascular dysplasia.
Related Concept Videos
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...